Pfizer Inc (PFE)

Industry Drug Manufacturers - General


This stock can be held in an Investment ISA and an Investment Account
Sell

$24.09

Buy

$24.10

arrow-down$-0.315 (-1.29%)

Prices updated at 01 May 2025, 19:41 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.

Most recent dividend payment

0.430
Cash Dividend
09 May 2025
23 Apr 2025
09 May 2025
13 Jun 2025

Total dividend yield

Created with Highcharts 7.2.2Total yield (%)Total yield (%)2021202220232024202502468

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20250.8600-
20241.68000.02
20231.64000.03
20221.60000.03
20211.56000.03
20201.52000.06
20191.44000.06
20181.36000.06
20171.28000.07
20161.20000.07

Total dividend yield data table

Dividend yield (%)Buyback yield (%)
20256.67-
20246.33-
20235.70-
20223.120.70
20212.64-
20204.13-
20193.686.41
20183.122.87
20173.532.32
20163.692.54

Dividend per share

Created with Highcharts 7.2.2Dividend per shareDividend per share2021202220232024202500.511.52

% of earnings paid to shareholders

Created with Highcharts 7.2.2Payout ratio (%)Payout ratio (%)20212022202320242025050100150200250

Dividend per share data table

YearDividend per share
20250.8600
20241.6800
20231.6400
20221.6000
20211.5600
20201.5200
20191.4400
20181.3600
20171.2800
20161.2000

% of earnings paid to shareholders data table

YearPayout ratio (%)
2025119.15
2024222.67
202389.07
202230.46
202145.06
202096.77
201949.65
201833.92
201777.78
2016118.00
Latest Financial Report as of 30 Apr 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.